89Zr-trastuzumab
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for 89Zr-trastuzumab, covering 2013-05-14 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer [Phase 2]